Ben Sasse's latest pancreatic cancer update comes amid his stark warning about America's future
The former Nebraska senator, given three to four months to live, entered a clinical trial for daraxonrasib...
Redirecting to full article...
The former Nebraska senator, given three to four months to live, entered a clinical trial for daraxonrasib...
Redirecting to full article...